These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7536716)

  • 1. Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.
    Farivar RS; Crawford DC; Chobanian AV; Brecher P
    Hypertension; 1995 Apr; 25(4 Pt 2):809-13. PubMed ID: 7536716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous angiotensin II enhances phenylephrine-induced tone in hypertensive rats.
    Qiu HY; Henrion D; Levy BI
    Hypertension; 1994 Sep; 24(3):317-21. PubMed ID: 8082938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M; Yuan B; Harmsen E; Leenen FH
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
    Omura T; Kim S; Takeuchi K; Iwao H; Takeda T
    Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
    Ruzicka M; Leenen FH
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan (DuP753) and enalaprilat on the mean arterial pressure response to phenylephrine.
    Madwed JB; Winquist RJ
    J Hypertens; 1994 Feb; 12(2):159-62. PubMed ID: 8021467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.
    Smits JF; van Krimpen C; Schoemaker RG; Cleutjens JP; Daemen MJ
    J Cardiovasc Pharmacol; 1992; 20(5):772-8. PubMed ID: 1280740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition.
    Valentin JP; Nafrialdi N; Ribstein J; Mimran A
    Am J Physiol; 1993 Apr; 264(4 Pt 2):R676-80. PubMed ID: 8386485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renin-angiotensin system in neointima formation after injury in rabbits.
    Janiak P; Libert O; Vilaine JP
    Hypertension; 1994 Dec; 24(6):671-8. PubMed ID: 7995623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
    Nakano M; Kanda T; Matsuzaki S; Hasegawa S; Ma H; Imai S; Suzuki T; Kobayashi I
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.